DURING the National Institute for Clinical Excellence's (NICE) two-and-a-half years of dithering over whether beta interferon should be prescribed to multiple sclerosis sufferers I have written many letters on the subject, a number to our local MP, Cheryl Gillan.
Now that NICE have decided not to recommend its prescription on the grounds that it is not cost-effective Mrs Gillan has sent me a number of items updating the position.
Amongst those items is a 22-page glossy brochure published by NICE entitled "Technology Appraisal Guidance-No 32 Beta interferon and glatiramer acetate for the treatment of multiple sclerosis", dated January 2002.
I wonder what it has cost to produce this brochure and how that compares with the cost of prescribing drugs to MS sufferers?
Spencer Arnott
Beech Tree Road
Holmer Green
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereComments are closed on this article